Evista, illustration of tablet form (not a photo of the actual pack)

Illustrative image.

Evista

Raloxifene

Prescription required

$99.00

60mg · 3 × 28 tablets · 3 months supply

GenericGeneric medicine

$33.00 per month

How long a supply?

1 month$33.00 a month
3 months$33.00 a month
6 months$33.00 a month
Supplied from UK

Test mode: no payment is taken. View cart

Annual cost

$429a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

FDA boxed warningIncreased risk of venous thromboembolism and death from stroke

Increased risk of deep vein thrombosis and pulmonary embolism have been reported with EVISTA

. Women with active or past history of venous thromboembolism should not take EVISTA

Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events. Consider risk-benefit balance in women at risk for stroke

Read this with the rest of the clinical information

About Evista

Overview

Evista (raloxifene hydrochloride) is a prescription medicine called a selective estrogen receptor modulator (SERM). It is used to treat and prevent osteoporosis in postmenopausal women and to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or are at high risk for invasive breast cancer. It acts like estrogen in bone to reduce bone breakdown and blocks estrogen activity in some other tissues. Evista is not used to treat breast cancer, prevent its recurrence or reduce the risk of noninvasive breast cancer.

What it treats

- Treatment and prevention of osteoporosis in postmenopausal women. - Reduction of invasive breast cancer risk in postmenopausal women with osteoporosis or at high risk for invasive breast cancer. Evista is not used to treat invasive breast cancer, reduce the risk of breast cancer recurrence, or reduce the risk of noninvasive breast cancer.

Safety information

Side effects

Common side effects include hot flashes, leg cramps, swelling of the hands or feet, flu-like symptoms, joint pain and sweating. Serious risks include blood clots in the deep veins, lungs or veins of the eye. Contact a doctor immediately if a blood clot is suspected. Evista also increased the risk of death due to stroke in a trial involving postmenopausal women with coronary heart disease or an increased risk of major coronary events, although the overall risk of stroke was not increased in that trial. Suspected stroke requires immediate medical attention.

FDA boxed warning

Increased risk of venous thromboembolism and death from stroke

Increased risk of deep vein thrombosis and pulmonary embolism have been reported with EVISTA

. Women with active or past history of venous thromboembolism should not take EVISTA

Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events. Consider risk-benefit balance in women at risk for stroke

A boxed warning is the strongest warning the US Food and Drug Administration requires on a medicine label. Text is taken from the official label, with internal section references removed.

Before taking this medicine

Do not take Evista if you are pregnant or have ever had a blood clot in a vein, including deep vein thrombosis, a clot in the lungs (pulmonary embolism), or a clot in a retinal vein in the eye. Evista increases the risk of these blood clots. It should be stopped 72 hours before and during prolonged periods of immobility. Use requires caution if you have liver impairment or are at risk of stroke. In a trial involving postmenopausal women with coronary heart disease or an increased risk of major coronary events, Evista increased the risk of death due to stroke, although the overall risk of stroke was not increased. Evista should not be used to prevent cardiovascular disease. Use is not recommended before menopause or together with systemic estrogens. If previous estrogen treatment caused high triglyceride levels, blood triglycerides should be monitored. Safety and effectiveness in children have not been established.

Interactions

Tell your doctor if you take cholestyramine, warfarin, diazepam, diazoxide or lidocaine. Cholestyramine reduces raloxifene absorption and its recycling in the body, so using it with Evista is not recommended. If you take warfarin, your doctor should monitor your blood-clotting time (prothrombin time) when you start or stop Evista. Medicines that bind strongly to blood proteins, including diazepam, diazoxide and lidocaine, should be used with Evista cautiously.

Using Evista

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label EVISTA (RALOXIFENE HYDROCHLORIDE) TABLET [ELI LILLY AND COMPANY] (DailyMed, retrieved 19 September 2026).

Patient information and references

Official and supporting information to read alongside advice from your prescriber or pharmacist.

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines